PBE vs. VHT
PBE (Invesco Dynamic Biotechnology & Genome ETF) and VHT (Vanguard Health Care ETF) are both Health & Biotech Equities funds - PBE tracks the Dynamic Biotech & Genome Intellidex Index (AMEX) while VHT tracks the MSCI US Investable Market Health Care 25/50 Index. Both are passively managed. Over the past 10 years, PBE returned 7.55%/yr vs 9.26%/yr for VHT. A 0.79 correlation means they provide meaningful diversification when combined. PBE charges 0.59%/yr vs 0.09%/yr for VHT.
Performance
PBE vs. VHT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 0.58% return, which is significantly higher than VHT's -4.02% return. Over the past 10 years, PBE has underperformed VHT with an annualized return of 7.55%, while VHT has yielded a comparatively higher 9.26% annualized return.
PBE
- 1D
- 2.04%
- 1M
- 2.68%
- YTD
- 0.58%
- 6M
- 1.15%
- 1Y
- 30.26%
- 3Y*
- 10.44%
- 5Y*
- 3.06%
- 10Y*
- 7.55%
VHT
- 1D
- 0.84%
- 1M
- 1.45%
- YTD
- -4.02%
- 6M
- -4.15%
- 1Y
- 14.34%
- 3Y*
- 6.14%
- 5Y*
- 4.51%
- 10Y*
- 9.26%
PBE vs. VHT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.58% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
VHT Vanguard Health Care ETF | -4.02% | 15.46% | 2.66% | 2.52% | -5.60% | 20.57% | 18.29% | 21.87% | 5.58% | 23.26% |
Correlation
The correlation between PBE and VHT is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.78 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.74 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.76 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.77 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2005 | 0.79 |
The correlation between PBE and VHT has been stable across timeframes, ranging from 0.74 to 0.79 - a consistent structural relationship.
PBE vs. VHT - Sectors Allocation Comparison
Sectors
PBE
VHT
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
PBE
VHT
Financial Services
PBE
VHT
Basic Materials
PBE
-
VHT
-
Communication Services
PBE
-
VHT
-
Consumer Cyclical
PBE
-
VHT
-
Consumer Defensive
PBE
-
VHT
-
Energy
PBE
-
VHT
-
Industrials
PBE
-
VHT
Real Estate
PBE
-
VHT
-
Technology
PBE
-
VHT
Utilities
PBE
-
VHT
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. VHT — Risk / Return Rank
PBE
VHT
PBE vs. VHT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | VHT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.62 | ||
| Sortino ratioReturn per unit of downside risk | +0.87 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.18 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 2.59 | 1.38 | +1.21 |
| Martin ratioReturn relative to average drawdown | 7.27 | 3.47 | +3.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PBE | VHT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.63 | 1.00 | +0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | 0.30 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | 0.55 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.56 | -0.23 |
Drawdowns
PBE vs. VHT - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for PBE and VHT.
Loading charts...
Drawdown Indicators
| PBE | VHT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -39.12% | -6.57% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -10.40% | -1.33% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | -16.91% | -5.52% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -17.71% | -17.00% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -28.85% | -8.99% |
Current DrawdownCurrent decline from peak | -3.62% | -7.05% | +3.43% |
Average DrawdownAverage peak-to-trough decline | -16.24% | -5.99% | -10.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 4.14% | +0.03% |
Volatility
PBE vs. VHT - Volatility Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) has a higher volatility of 5.63% compared to Vanguard Health Care ETF (VHT) at 4.08%. This indicates that PBE's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | VHT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.63% | 4.08% | +1.55% |
Volatility (6M)Calculated over the trailing 6-month period | 13.27% | 10.08% | +3.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.71% | 14.34% | +4.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.54% | 14.96% | +7.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.92% | 16.94% | +7.98% |
PBE vs. VHT - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is higher than VHT's 0.09% expense ratio.
Dividends
PBE vs. VHT - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.05%, less than VHT's 1.71% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.05% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
VHT Vanguard Health Care ETF | 1.71% | 1.61% | 1.53% | 1.36% | 1.33% | 1.14% | 1.21% | 1.89% | 1.38% | 1.31% | 1.45% | 1.22% |
Frequently Asked Questions
PBE and VHT have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PBE has higher volatility (5.63%) compared to VHT (4.08%). In terms of maximum drawdown, PBE dropped -45.69% vs VHT's -39.12%.
On 10-year performance, VHT leads with 9.26% vs 7.55% for PBE. On fees, VHT is cheaper at 0.09% per year. On volatility, VHT has been the lower-risk option at 4.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VHT has performed better with a 9.26% return vs 7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VHT is cheaper with a 0.09% expense ratio, compared with 0.59% for PBE.
VHT has the higher dividend yield at 1.71%, compared with 1.05% for PBE.
PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while VHT tracks MSCI US Investable Market Health Care 25/50 Index. They also come from different issuers: Invesco and Vanguard. Their fees differ too: 0.59% for PBE and 0.09% for VHT.
PBE currently has the higher Sharpe Ratio (1.63 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and VHT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer